Tokyo (JCNN) - Sharp announced on June 6 that it has verified the effectiveness of Plasmacluster Ions, its proprietary air-purifying technology, in collaboration with Retroscreen Virology, Ltd, a UK contract virology research company.
Their recent research showed that Plasmacluster Ions effectively deactivates H5N1 avian influenza virus, specifically, lowering its activity level by 99%. This is the first air-purifying technology that has demonstrated the efficacy against H5N1 virus.
Developed in 2000, Plasmacluster Ions can sanitize the air by releasing both positive and negative ions. Retroscreen Virology, which is founded by University of London School of Medicine & Dentistry Professor John S. Oxford in 1989, has a well established track record in virological research and clinical trials.
View Sharp Corporation company profile here
Copyright © 2005 JCNN. All rights reserved. A division of Japan Corporate News Network KK.
Комментариев нет:
Отправить комментарий